TrialInflammopharmacology2021

A pilot safety, tolerability and pharmacokinetic study of an oro-buccal administered cannabidiol-dominant anti-inflammatory formulation in healthy individuals: a randomized placebo-controlled single-blinded study.

Luis Vitetta et al.PubMed ↗Publisher ↗

No numbers read from the abstract.